Genentech Block Out Cancer Program
Genentech Blocked Shots Counter |
|
 Click here for more information about the Children's Cancer Association The Trail Blazers teamed up with Genentech and the Children’s Cancer Association (CCA) for a third year for the ‘Block Out Cancer’ campaign. As part of the program, Genentech donated $25 to CCA every time the Trail Blazers blocked a shot this season. The Portland Trail Blazers also lent an assist with an additional grant. At the end of the season Genentech and the make it better foundation made a combined donation of $15,000 to the CCA. Funds raised through the “Block Out Cancer” campaign will support CCA programs helping children and their families battling cancer and other serious illnesses. Founded more than a decade ago by a family who has been there, the Children’s Cancer Association brings JoyRx to seriously ill children and their families, in the hospital and at home. When families need support, CCA is there with award-winning programs and resources, available at no cost to those in need, in Oregon, Southwest Washington and across the nation. Keep checking back to see how the Trail Blazers are teaming up with Genentech and CCA to Block Out Cancer. ABOUT CCA When seriously ill children and their families need more than medicine, CCA’s innovative programs create joy one moment at a time. Fueled by award-winning innovative programs and resources CCA brings the healing power of compassion, music and friendship to seriously ill children and their families when they need it most. Powered by thousands of supporters and volunteers and available at no cost to families, CCA programs include an in-hospital Music Rx® program, Chemo Pal® mentor program, LifeSupport Family Enrichment program, and Caring Cabin® retreat home on the Oregon coast. To learn how to get involved please visit www.JoyRx.org ABOUT GENENTECH Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com 
|
|
